Definition and aetiology of non-CF bronchiectasis

Robert Wilson, David M. Hansell, Michael R. Loebinger

Source: Eur Respir Monogr 2013; 60: 107-119

Journal Issue: The Spectrum of Bronchial Infection

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Robert Wilson, David M. Hansell, Michael R. Loebinger. Definition and aetiology of non-CF bronchiectasis. Eur Respir Monogr 2013; 60: 107-119

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Bronchopulmonary aspergillosis Source: Respipedia Article Year: 2017
Respiratory infections in primary ciliary dyskinesia and non-CF bronchiectasis Source: ERS Courses: Paediatric respiratory infections Year: 2019
Non-cystic fibrosis bronchiectasis in children Source: Annual Congress 2005 - MP11 - Non-cystic fibrosis bronchiectasis in children Year: 2005
Hypereosinophilic obliterative bronchiolitis: a distinct, unrecognised syndrome Source: Eur Respir J 2013; 41: 1126-1134 Year: 2013
Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis Source: Eur Respir J 2006; 28: 352-357 Year: 2006
Long term follow up of the lung function in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009
Medicines used in respiratory diseases only seen in children Source: Eur Respir J 2009; 34: 531 Year: 2009
Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2014; 43: 1487-1500 Year: 2014
Risk factors for allergic bronchopulmonary aspergillosis in paediatric patients with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010
Impact of bacterial infections on airway diseases Source: Eur Respir Rev 2005; 14: 62-68 Year: 2005
Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Source: Eur Respir Rev 2010 19: 261-263 Year: 2010
Chronic rhinosinusitis in non-cystic fibrosis bronchiectasis and primary ciliary dyskinesia Source: Eur Respir Monogr 2017; 76: 148-161 Year: 2017
Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014
Management of chronic airway infection in bronchiectasis Source: Virtual Congress 2020 – The future of bronchiectasis management Year: 2020
Prevalence of possible severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) in a UK secondary care hospital Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013
Bronchiectasis: epidemiology and causes Source: Eur Respir Mon 2011; 52: 1-10 Year: 2011
Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015